Longevity investing

Global pandemics & accelerated investment in Longevity

Dmitry Kaminskiy, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics.

The crucial question in Longevity investing: is it repair?

Reason, Co-founder and CEO, Repair Biotechnologies & Fight Aging!

Genome editing: opportunity & anxiety in equal measure

James Lawford Davies, Partner, Hill Dickinson

How to identify new targets and indications for aging drug development

Simon Melov, Professor, Buck Institute and Founder and CEO, Gerostate Alpha

Risk & reward: Longevity investments

Ronjon Nag, Managing Director and Founder, R42 Group

5 investment lessons from coronavirus

Sergey Young, Founder, Longevity Vision Fund.

‘Longevity investing’ Ask Me Anything

Various speakers from the conference come together to answer your questions on Longevity investing.

Latest articles

Selfie biomarkers: AI and insurtech implications for Longevity

AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...

Low levels of stress hormone contributes to aging

When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany.  There have been plenty of studies that...

Rejuvenation Roadmap charts life extension progress

We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...

Longevity therapies delivered through skin is a topical issue

Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...